The limited potential of murine monoclonal antibodies for human immunotherapy has driven recent progress in recombinant antibody technology. Here, de Kruif and colleagues report on advances in the development and use of phage-antibody-display libraries.

doi.org/10.1016/0167-5699(96)30057-Y, hdl.handle.net/1765/59062
Immunology Today
Department of Immunology

de Kruif, J., van der Vuurst de Vries, A., Cilenti, L., Boel, E., van Ewijk, W., & Logtenberg, T. (1996). New perspectives on recombinant human antibodies. Immunology Today, 17(10), 453–455. doi:10.1016/0167-5699(96)30057-Y